{"cells":[{"cell_type":"code","source":["dbutils.fs.head(\"/FileStore/tables/clinicaltrial_2021.csv/clinicaltrial_2021.csv\")"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"0e75e358-5463-44c1-9973-86bc5c64a367","inputWidgets":{},"title":""}},"outputs":[{"output_type":"stream","output_type":"stream","name":"stdout","text":["[Truncated to first 65536 bytes]\nOut[1]: \"Id|Sponsor|Status|Start|Completion|Type|Submission|Conditions|Interventions\\r\\nNCT02758028|The University of Hong Kong|Recruiting|Aug 2005|Nov 2021|Interventional|Apr 2016||\\r\\nNCT02751957|Duke University|Completed|Jul 2016|Jul 2020|Interventional|Apr 2016|Autistic Disorder,Autism Spectrum Disorder|\\r\\nNCT02758483|Universidade Federal do Rio de Janeiro|Completed|Mar 2017|Jan 2018|Interventional|Apr 2016|Diabetes Mellitus|\\r\\nNCT02759848|Istanbul Medeniyet University|Completed|Jan 2012|Dec 2014|Observational|May 2016|Tuberculosis,Lung Diseases,Pulmonary Disease|\\r\\nNCT02758860|University of Roma La Sapienza|Active, not recruiting|Jun 2016|Sep 2020|Observational [Patient Registry]|Apr 2016|Diverticular Diseases,Diverticulum,Diverticulosis|\\r\\nNCT02757209|Consorzio Futuro in Ricerca|Completed|Apr 2016|Jan 2018|Interventional|Apr 2016|Asthma|Fluticasone,Xhance,Budesonide,Formoterol Fumarate,Salmeterol Xinafoate\\r\\nNCT02752438|Ankara University|Unknown status|May 2016|Jul 2017|Observational [Patient Registry]|Apr 2016|Hypoventilation|\\r\\nNCT02753543|Ruijin Hospital|Unknown status|Nov 2015|Nov 2019|Interventional|Apr 2016|Lymphoma|\\r\\nNCT02757508|Washington University School of Medicine|Completed|Mar 2016|Jul 2017|Interventional|Apr 2016||Vitamins\\r\\nNCT02753530|Orphazyme|Completed|Aug 2017|Jan 2021|Interventional|Apr 2016|Myositis|\\r\\nNCT02754817|Novo Nordisk A/S|Completed|Apr 2016|Oct 2016|Observational|Apr 2016|Diabetes Mellitus|Liraglutide,Xultophy\\r\\nNCT02759276|Daniel Alexandre Bottino|Completed|May 2015|Dec 2015|Observational|Apr 2016|Hypertension|\\r\\nNCT02750956|Bulent Ecevit University|Completed|Jun 2015|Mar 2016|Observational|Apr 2016|Periodontal Diseases|\\r\\nNCT02752113|Institut für Pharmakologie und Präventive Medizin|Completed|Apr 2016|May 2019|Interventional|Apr 2016|Diabetes Mellitus|Metformin,Empagliflozin,Linagliptin\\r\\nNCT02752698|The Third Xiangya Hospital of Central South University|Active, not recruiting|Jan 2015|Dec 2021|Interventional|Jun 2015|Appendicitis,Stomach Ulcer,Cholecystolithiasis,Cholelithiasis,Gallstones|\\r\\nNCT02755779|Tel Aviv Medical Center|Unknown status|Jun 2016|Jun 2017|Observational|Apr 2016||\\r\\nNCT02750384|Medicines for Malaria Venture|Terminated|May 2016|Jul 2016|Interventional|Apr 2016||\\r\\nNCT02754609|James Cook University, Queensland, Australia|Completed|Sep 2016|Oct 2019|Interventional|Apr 2016|Hookworm Infections,Celiac Disease|\\r\\nNCT02755701|Soonchunhyang University Hospital|Unknown status|Jul 2016|Dec 2018|Interventional|Apr 2016|Ascites|\\r\\nNCT02751762|Member Companies of the Opioid PMR Consortium|Recruiting|Nov 2017|Oct 2022|Observational|Apr 2016|Chronic Pain,Substance-Related Disorders,Opioid-Related Disorders,Narcotic-Related Disorders,Behavior|\\r\\nNCT02756299|Marmara University|Completed|Jun 2014|Apr 2015|Interventional|Apr 2016|Sleep Apnea Syndromes,Sleep Apnea|\\r\\nNCT02750709|Cycle Pharmaceuticals Ltd.|Completed|Oct 2015|Jan 2016|Interventional|Apr 2016|Tyrosinemias|Nitisinone\\r\\nNCT02753907|Yonsei University|Completed|Jun 2015||Interventional|Apr 2016||\\r\\nNCT02755467|Cutera Inc.|Completed|May 2016|Apr 2017|Interventional|Apr 2016|Hemangioma|\\r\\nNCT02755298|University of Zurich|Completed|Oct 2016|Nov 2020|Interventional|Mar 2016|Hypertension|Acetazolamide\\r\\nNCT02759614|Guangdong Association of Clinical Trials|Unknown status|Apr 2016|Jun 2019|Interventional|Mar 2016|Carcinoma|Bevacizumab,Erlotinib Hydrochloride\\r\\nNCT02752815|Ruijin Hospital|Unknown status|Apr 2016|Jun 2020|Interventional|Apr 2016|Lymphoma|Prednisone,Cyclophosphamide,Rituximab,Vincristine,Epirubicin\\r\\nNCT02757131|The Cleveland Clinic|Completed|Jul 2016|Jul 2017|Interventional|Apr 2016|Iatrogenic Disease|\\r\\nNCT02758704|St. Justine's Hospital|Completed|Oct 2015|Jun 2021|Interventional|Apr 2016||\\r\\nNCT02750501|Alcresta Therapeutics, Inc.|Completed|Jul 2016|Mar 2017|Interventional|Apr 2016|Cystic Fibrosis,Fibrosis|\\r\\nNCT02759913|Iron Horse Diagnostics, Inc.|Unknown status|Jan 2015|Dec 2016|Observational|Apr 2016|Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Sclerosis|\\r\\nNCT02752724|VA Puget Sound Health Care System|Completed|Mar 2016|Apr 2018|Interventional|Mar 2016|Depressive Disorder,Depression|Ketamine,Methohexital\\r\\nNCT02758444|University of Colorado, Denver|Completed|Nov 2015|Feb 2019|Interventional|Apr 2016||Micronutrients,Trace Elements\\r\\nNCT02758067|H. Lundbeck A/S|Withdrawn|Jun 2016||Interventional|Apr 2016|Schizophrenia|Risperidone,Brexpiprazole\\r\\nNCT02759341|Ospedale San Giovanni Bellinzona|Completed|Feb 2016|Nov 2017|Interventional|Apr 2016|Myocardial Infarction,Cardiomyopathies,Microvascular Angina,Takotsubo Cardiomyopathy,Syndrome,Infarction|\\r\\nNCT02753803|Dong-A ST Co., Ltd.|Completed|Jul 2016|Mar 2017|Interventional|Apr 2016||Pioglitazone\\r\\nNCT02752490|The University of Texas Health Science Center, Houston|Completed|Apr 2016|Jul 2016|Interventional|Apr 2016||\\r\\nNCT02759562|Gilead Sciences|Terminated|Nov 2016|Jul 2017|Interventional|Apr 2016|Cystic Fibrosis,Fibrosis|\\r\\nNCT02758262|Laval University|Unknown status|Apr 2016|Dec 2017|Interventional|Apr 2016|Hyperphagia|\\r\\nNCT02754258|Children's Hospital of Eastern Ontario|Unknown status|Jan 2017|Dec 2018|Interventional|Apr 2016||Methylphenidate\\r\\nNCT02755207|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Unknown status|Apr 2016|Dec 2020|Observational|Mar 2016|Acute Coronary Syndrome,Syndrome|\\r\\nNCT02759900|The Skin Center Dermatology Group|Recruiting|Jan 2016|Jan 2023|Interventional|Apr 2016|Molluscum Contagiosum,Keratosis,Bowens Disease,Rosacea,Skin Diseases|\\r\\nNCT02752581|Mert Özcan|Completed|Jan 2009|Apr 2013|Interventional|Apr 2016|Hemarthrosis|\\r\\nNCT02759796|Instituto de Investigación Hospital Universitario La Paz|Completed|Nov 2015|Apr 2017|Interventional|Apr 2016|Necrosis,Neovascularization,Fat Necrosis|\\r\\nNCT02754063|University Hospital, Grenoble|Active, not recruiting|Jun 2016|Apr 2022|Interventional|Apr 2016|Brain Injuries,Wounds and Injuries|3\\r\\nNCT02750917|Foisor Orthopedics Clinical Hospital|Completed|Sep 2014|Mar 2015|Interventional|Feb 2016|Pain|Etoricoxib,Lornoxicam\\r\\nNCT02753569|Institute of Cancer Research, United Kingdom|Completed|May 2016|May 2020|Observational|Apr 2016||\\r\\nNCT02751255|VU University Medical Center|Active, not recruiting|Jul 2016|Mar 2022|Interventional|Apr 2016|Multiple Myeloma,Neoplasms|Tretinoin\\r\\nNCT02751528|NantBioScience, Inc.|Unknown status|Dec 2016|Dec 2020|Interventional|Apr 2016|Breast Neoplasms|Vaccines\\r\\nNCT02751619|University of Campania Luigi Vanvitelli|Completed|Jan 2013|Dec 2015|Interventional|Apr 2016|Pain|Lidocaine\\r\\nNCT02757833|Lawson Health Research Institute|Withdrawn|Feb 2019|Feb 2019|Interventional|Apr 2016|Depression,Depressive Disorder|\\r\\nNCT02750761|Merck Sharp & Dohme Corp.|Completed|May 2016|Dec 2018|Interventional|Apr 2016|Infections,Bacterial Infections,Gram-Positive Bacterial Infections|Tedizolid phosphate,Tedizolid,Oxazolidinones\\r\\nNCT02752594|Sharda University|Completed|Apr 2015|Apr 2015|Interventional|Apr 2016|Dental Caries|\\r\\nNCT02753452|Holland Bloorview Kids Rehabilitation Hospital|Unknown status|May 2015|Mar 2020|Interventional|Apr 2016||\\r\\nNCT02752763|Niğde State Hospital|Completed|Oct 2015|Mar 2016|Interventional|Mar 2016|Dry Eye Syndromes,Keratoconjunctivitis Sicca|Dextrans,Povidone,Ophthalmic Solutions,Lubricant Eye Drops\\r\\nNCT02753816|Spectrum Health Hospitals|Terminated|Apr 2016|Dec 2019|Interventional|Apr 2016|Burns|Tranexamic Acid\\r\\nNCT02751294|GlaxoSmithKline|Completed|May 2016|Aug 2016|Interventional|Apr 2016|Malaria|Tafenoquine\\r\\nNCT02756429|Hospices Civils de Lyon|Completed|Feb 2014|Jan 2018|Interventional|Apr 2016|Atrial Fibrillation|\\r\\nNCT02750163|Università Politecnica delle Marche|Completed|Jul 2017|Jun 2019|Observational|Apr 2016|Shock|Acetaminophen\\r\\nNCT02751905|Biogen|Completed|Apr 2016|May 2016|Interventional|Apr 2016|Neuralgia|\\r\\nNCT02753153|University of Liege|Completed|May 2011|May 2015|Interventional|Apr 2016|Tooth Loss|\\r\\nNCT02750891|Sumitomo Dainippon Pharma Co., Ltd.|Completed|Apr 2016|Jan 2020|Interventional|Apr 2016|Glioblastoma,Glioma,Diffuse Intrinsic Pontine Glioma|\\r\\nNCT02751073|Mayo Clinic|Completed|Feb 2016|Jul 2018|Observational|Feb 2016|Infections,Communicable Diseases,Urinary Tract Infections,Prolapse,Pelvic Organ Prolapse|\\r\\nNCT02753114|University of British Columbia|Completed|Nov 2017|May 2018|Interventional|Apr 2016|Acute Pain|Ketamine\\r\\nNCT02752516|Chia Tai Tianqing Pharmaceutical Group Co., Ltd.|Unknown status|Apr 2016|Dec 2017|Interventional|Apr 2016||\\r\\nNCT02752269|Medical University of Graz|Completed|Oct 2014|Jun 2019|Observational|Nov 2015|Sjogrens Syndrome,Hypertension,Vascular Diseases,Syndrome|\\r\\nNCT02754713|Hippocration General Hospital|Recruiting|Sep 2009|Dec 2025|Observational|Apr 2016|Pericarditis|\\r\\nNCT02759770|Beijing Anzhen Hospital|Completed|Jul 2017|Sep 2017|Observational|Apr 2016|Respiratory Distress Syndrome,Acute Lung Injury|\\r\\nNCT02755129|Medtronic BRC|Completed|Sep 2016|Jul 2017|Interventional|Mar 2016|Frailty|\\r\\nNCT02754674|Samsung Medical Center|Completed|May 2014|Dec 2017|Interventional|Feb 2015|Rupture|\\r\\nNCT02757521|Washington University School of Medicine|Terminated|Mar 2016|Dec 2016|Interventional|Apr 2016|Disease,Depression,Depressive Disorder,Bipolar Disorder|Nitrous Oxide\\r\\nNCT02750774|University of Modena and Reggio Emilia|Unknown status|Dec 2015|Dec 2016|Interventional|Apr 2016|Diabetes,Obesity,Pregnancy Complications,Fetal Macrosomia,Overweight,Birth Weight|\\r\\nNCT02754739|Samsung Medical Center|Completed|Apr 2014|Aug 2017|Interventional|Apr 2016|Diabetes Mellitus,Prediabetic State|Pravastatin\\r\\nNCT02758808|University of Michigan|Recruiting|Mar 2016|Oct 2023|Observational [Patient Registry]|Apr 2016|Lung Diseases,Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis|\\r\\nNCT02751840|Tel Hai College|Completed|Oct 2014|Apr 2016|Interventional|Apr 2016|Asymptomatic Diseases|Caffeine\\r\\nNCT02752451|University of Arizona|Completed|Mar 2015|Apr 2015|Interventional|Apr 2016||\\r\\nNCT02757599|Rigshospitalet, Denmark|Completed|Aug 2016|Jun 2017|Interventional|Apr 2016||\\r\\nNCT02753894|Astellas Pharma Inc|Completed|Jan 2008|Jun 2008|Interventional|Mar 2016|Kidney Diseases,Renal Insufficiency,Hyperphosphatemia|\\r\\nNCT02757638|Texas A&M University|Active, not recruiting|Oct 2015|Oct 2021|Interventional|Feb 2016|Weight Loss|\\r\\nNCT02757378|Kevin Farrell|Completed|May 2015|Sep 2015|Interventional|Apr 2016|Back Pain,Low Back Pain|\\r\\nNCT02751489|Bayer|Completed|May 2016|May 2016|Interventional|Apr 2016|Dermatitis|\\r\\nNCT02759315|Merck Sharp & Dohme Corp.|Terminated|May 2016|Nov 2017|Interventional|Apr 2016|Hepatitis A,Hepatitis C,Hepatitis|Uprifosbuvir,Ruzasvir\\r\\nNCT02754895|Massachusetts General Hospital|Completed|Oct 2014|May 2017|Interventional|Apr 2016|Acute Coronary Syndrome,Syndrome|\\r\\nNCT02750475|Bayer|Completed|May 2016|May 2016|Interventional|Apr 2016|Dermatitis|Sunscreening Agents\\r\\nNCT02755064|Adil Bharucha|Completed|Jun 2010|Nov 2013|Interventional|Apr 2016|Diabetes Mellitus|Erythromycin,Erythromycin Estolate,Erythromycin Ethylsuccinate,Erythromycin stearate,Erythromycin lactobionate\\r\\nNCT02758002|University of California, San Diego|Withdrawn|Jan 2016|Dec 2018|Interventional|Apr 2016|Atrial Fibrillation|\\r\\nNCT02755142|medac GmbH|Completed|Feb 2000|Jun 2001|Interventional|Apr 2016|Glioma,Brain Neoplasms|Aminolevulinic Acid\\r\\nNCT02756364|Millennium Pharmaceuticals, Inc.|Completed|Jul 2016|Nov 2019|Interventional|Apr 2016|Breast Neoplasms|Fulvestrant\\r\\nNCT02759484|Rush University Medical Center|Unknown status|Mar 2015|Mar 2019|Interventional|Dec 2015|Hypertension,Diabetes Mellitus,Hyperglycemia|\\r\\nNCT02752061|Harvard School of Public Health (HSPH)|Completed|May 2016|Jul 2020|Interventional|Apr 2016||\\r\\nNCT02756598|Aarhus University Hospital|Completed|Jan 2015|Jun 2018|Interventional|Dec 2015||Sufentanil,Dsuvia,Propofol\\r\\nNCT02755727|Royal Devon and Exeter NHS Foundation Trust|Completed|Mar 2016|Sep 2017|Interventional|Apr 2016|Tennis Elbow|\\r\\nNCT02754882|Samsung Bioepis Co., Ltd.|Completed|Jul 2016|Oct 2018|Interventional|Mar 2016|Lung Neoplasms,Carcinoma|Paclitaxel,Bevacizumab,Carboplatin\\r\\nNCT02754778|Martin-Luther-Universität Halle-Wittenberg|Completed|Apr 2016|Mar 2021|Interventional|Apr 2016|Pre-Eclampsia,HELLP Syndrome,Syndrome|\\r\\nNCT02758171|Boehringer Ingelheim|Completed|May 2016|Aug 2016|Interventional|Apr 2016||Empagliflozin,Linagliptin\\r\\nNCT02755376|Samsung Medical Center|Completed|Jan 2014|Dec 2018|Interventional|Feb 2015||Hyaluronic Acid\\r\\nNCT02759016|Boehringer Ingelheim|Completed|Jun 2016|Jul 2019|Interventional|Apr 2016|Leukemia|BI 836826\\r\\nNCT02758457|University of Bologna|Completed|Jan 2008|Apr 2015|Interventional|Apr 2016||\\r\\nNCT02755519|Chongqing Medical University|Completed|May 2014|Oct 2016|Observational|Apr 2016|Hyperaldosteronism|\\r\\nNCT02758782|Charite University, Berlin, Germany|Completed|Sep 2016|Jan 2021|Interventional|Apr 2016|Spondylitis|Celecoxib,Golimumab\\r\\nNCT02756806|Cutera Inc.|Completed|Apr 2016|Sep 2016|Interventional|Apr 2016||\\r\\nNCT02756156|Kahramanmaras Sutcu Imam University|Unknown status|Apr 2016|Aug 2016|Observational|Mar 2016|Humeral Fractures|\\r\\nNCT02759458|Rush University Medical Center|Completed|Nov 2013|Jan 2017|Interventional|Apr 2016|Rotator Cuff Injuries|\\r\\nNCT02750982|Brown, Theodore R., M.D., MPH|Completed|Jul 2016|Aug 2018|Interventional|Apr 2016|Parkinson Disease,Multiple Sclerosis,Alzheimer Disease,Brain Injuries,Spinal Cord Injuries,Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Huntington Disease,Sclerosis,Wounds and Injuries|\\r\\nNCT02751502|NYU Langone Health|Terminated|Jan 2017|Feb 2021|Interventional|Apr 2016|Hemiplegia|\\r\\nNCT02752087|Eli Lilly and Company|Completed|Apr 2016|May 2016|Interventional|Apr 2016||\\r\\nNCT02756858|Anavex Life Sciences Corp.|Completed|Mar 2016|Nov 2020|Interventional|Mar 2016|Alzheimer Disease|\\r\\nNCT02758249|Konkuk University Medical Center|Completed|Jan 2016|Jan 2016|Interventional|Feb 2016||Propofol,Sevoflurane\\r\\nNCT02754570|University of Colorado, Denver|Completed|Jul 2016|Feb 2018|Interventional|Apr 2016|Glaucoma,Ocular Hypertension,Hypertension|Pilocarpine\\r\\nNCT02754102|Bayer|Completed|May 2016|May 2016|Interventional|Apr 2016|Dermatitis|Sunscreening Agents\\r\\nNCT02751593|Peking University People's Hospital|Unknown status|Jan 2016|Dec 2017|Interventional|Apr 2016|Thrombocytopenia,Purpura|Dexamethasone\\r\\nNCT02757014|Bayer|Completed|Oct 2015|Oct 2015|Interventional|Apr 2016||\\r\\nNCT02753062|Asan Medical Center|Recruiting|Aug 2015|Aug 2023|Interventional|Apr 2016|Lymphoma|Rituximab,Bendamustine Hydrochloride\\r\\nNCT02752425|Hospices Civils de Lyon|Completed|May 2016|May 2018|Interventional|Apr 2016|Speech Disorders|\\r\\nNCT02757300|Marienhospital Osnabrück|Unknown status|May 2016|Jul 2017|Interventional|Apr 2016|Pharyngitis|\\r\\nNCT02754180|Peking Union Medical College Hospital|Unknown status|Mar 2016|Mar 2021|Interventional|Apr 2016|Adenocarcinoma,Pancreatic Neoplasms|Gemcitabine\\r\\nNCT02752321|Northwell Health|Terminated|Aug 2016|Dec 2017|Interventional|Apr 2016||\\r\\nNCT02753595|Eisai Inc.|Terminated|Jul 2016|Aug 2019|Interventional|Apr 2016|Breast Neoplasms|\\r\\nNCT02755246|Charite University, Berlin, Germany|Completed|Apr 2016|Sep 2016|Interventional|Apr 2016|Cognitive Dysfunction|\\r\\nNCT02754115|Tata Memorial Centre|Recruiting|Apr 2016|Jan 2022|Observational|Mar 2016|Peritoneal Diseases|\\r\\nNCT02756897|M.D. Anderson Cancer Center|Active, not recruiting|Jul 2016|Jul 2024|Interventional|Apr 2016|Lymphoma,Leukemia|Venetoclax\\r\\nNCT02752334|Magrabi Eye & Ear Hospital|Completed|Sep 2015|Mar 2019|Interventional|Mar 2016||Magnesium Sulfate,Bupivacaine\\r\\nNCT02754791|Shaare Zedek Medical Center|Unknown status|May 2016|May 2017|Interventional|Apr 2016||\\r\\nNCT02754128|Holland Bloorview Kids Rehabilitation Hospital|Completed|Jun 2016|Oct 2017|Interventional|Apr 2016|Cerebral Palsy|\\r\\nNCT02751190|Umeå University|Completed|Sep 2013|Feb 2017|Observational [Patient Registry]|Apr 2016|Chronic Pain,Hernia|\\r\\nNCT02751645|Oregon Health and Science University|Unknown status|Jun 2016|May 2020|Interventional|Apr 2016||\\r\\nNCT02758184|Duke University|Terminated|Jun 2016|May 2018|Interventional|Apr 2016||\\r\\nNCT02751892|University of East Anglia|Completed|Oct 2013|Sep 2014|Interventional|Apr 2016|Colorectal Neoplasms|\\r\\nNCT02755324|Leiden University|Completed|Oct 2016|Jan 2019|Interventional|Apr 2016|Schistosomiasis|\\r\\nNCT02758886|Washington State University|Completed|Apr 2014||Interventional|Apr 2016|Stress|\\r\\nNCT02750072|Fraser Orthopaedic Research Society|Active, not recruiting|Sep 2016|Apr 2023|Interventional|Apr 2016|Patellofemoral Pain Syndrome,Fractures,Tibial Fractures|\\r\\nNCT02750332|Cycle Pharmaceuticals Ltd.|Completed|Nov 2015|Jan 2016|Interventional|Apr 2016|Tyrosinemias|Nitisinone\\r\\nNCT02752529|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|Unknown status|Mar 2016||Interventional|Mar 2016|Liver Cirrhosis|Tacrolimus\\r\\nNCT02759939|Dartmouth-Hitchcock Medical Center|Completed|Jul 2016|Jul 2017|Interventional|Feb 2016||\\r\\nNCT02757157|European Respiratory Society|Terminated|Oct 2016|Jan 2020|Interventional|Apr 2016|Lung Diseases,Pulmonary Disease|\\r\\nNCT02759627|Istanbul University|Completed|Nov 2014|Mar 2016|Interventional|Apr 2016|Stroke|\\r\\nNCT02752412|Sanofi|Completed|May 2016|Oct 2018|Interventional|Apr 2016|Diabetes Mellitus|Insulin,Metformin,Insulin Glargine,Lixisenatide\\r\\nNCT02756988|Bayer|Completed|Oct 2015|Oct 2015|Interventional|Apr 2016||\\r\\nNCT02751203|Lara McKenzie|Completed|Apr 2016|Dec 2017|Interventional|Mar 2016||\\r\\nNCT02753946|Nabriva Therapeutics AG|Completed|Apr 2016|May 2017|Interventional|Apr 2016|Infections,Communicable Diseases,Urinary Tract Infections,Pyelonephritis|Tazobactam,Piperacillin,Fosfomycin\\r\\nNCT02755480|University Health Network, Toronto|Terminated|Feb 2015|Feb 2017|Interventional|Mar 2015||\\r\\nNCT02753257|Valtari Bio|Unknown status|Sep 2016|Dec 2019|Observational|Apr 2016|Stroke|\\r\\nNCT02758691|Virginia Polytechnic Institute and State University|Completed|Dec 2015|May 2017|Interventional|Apr 2016||Insulin\\r\\nNCT02755623|Centre hospitalier de Ville-Evrard, France|Unknown status|May 2015|Dec 2018|Interventional|Apr 2016|Hallucinations,Schizophrenia|\\r\\nNCT02756234|Lancaster General Hospital|Completed|May 2016|Aug 2018|Observational|Apr 2016|Coronary Artery Disease|\\r\\nNCT02756091|University Hospital Inselspital, Berne|Recruiting|Aug 2016|May 2022|Observational [Patient Registry]|Apr 2016|Cerebrovascular Disorders|\\r\\nNCT02753491|Marmara University|Completed|Oct 2015|Mar 2016|Interventional|Apr 2016||\\r\\nNCT02752737|Medtronic Cardiac Rhythm and Heart Failure|Recruiting|May 2016|Dec 2024|Observational [Patient Registry]|Apr 2016|Atrial Fibrillation|\\r\\nNCT02758925|University Hospital, Caen|Unknown status|Jun 2016|Dec 2018|Interventional|Apr 2016|Lymphoma|Cytarabine,Rituximab,Bendamustine Hydrochloride\\r\\nNCT02751723|Florian Lordick, MD|Unknown status|Sep 2014|Oct 2019|Observational|Apr 2016||\\r\\nNCT02751931|Astellas Pharma Europe B.V.|Completed|Jun 2016|May 2019|Interventional|Apr 2016|Urinary Bladder|Mirabegron\\r\\nNCT02758847|Rabih A. Chaer|Recruiting|Sep 2016|Dec 2022|Interventional|Apr 2016|Ischemia|Paclitaxel,Albumin-Bound Paclitaxel\\r\\nNCT02757807|Eco Fusion|Unknown status|Jul 2016|Dec 2016|Interventional|Apr 2016|Erectile Dysfunction|\\r\\nNCT02755220|Shanghai Cingularbio Co. Ltd|Completed|Jan 2016|Apr 2019|Interventional|Apr 2016||\\r\\nNCT02758548|Novartis Pharmaceuticals|Completed|Mar 2016|May 2016|Interventional|Mar 2016||\\r\\nNCT02756845|Amgen|Recruiting|Aug 2017|Jun 2024|Interventional|Dec 2015|Neoplasms|Talimogene laherparepvec\\r\\nNCT02750605|Skane University Hospital|Active, not recruiting|Feb 2016|Dec 2021|Interventional|Jan 2016|Vascular Diseases,Peripheral Vascular Diseases,Peripheral Arterial Disease,Ischemia|\\r\\nNCT02756702|Aesculap AG|Active, not recruiting|Mar 2016|Dec 2022|Observational|Apr 2016|Osteoarthritis|\\r\\nNCT02752945|King's College London|Completed|Apr 2016|Dec 2016|Interventional|Apr 2016|Depression,Depressive Disorder,Anxiety Disorders|\\r\\nNCT02759952|STZ eyetrial|Enrolling by invitation|Jan 2013|Dec 2025|Observational|Apr 2016|Retinitis,Retinitis Pigmentosa|\\r\\nNCT02754661|Medtronic - MITG|Completed|Sep 2016|Aug 2018|Interventional|Apr 2016|Colorectal Neoplasms|\\r\\nNCT02755441|Nils Hoyer|Recruiting|Apr 2016|Dec 2024|Observational|Apr 2016|Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis|\\r\\nNCT02750098|Sheba Medical Center|Unknown status|May 2016|Mar 2018|Interventional|Apr 2016|Diabetes Mellitus|\\r\\nNCT02753179|Hospices Civils de Lyon|Completed|May 2016|Jan 2017|Interventional|Apr 2016|Vestibular Diseases|\\r\\nNCT02758509|Parc de Salut Mar|Completed|Jan 2010|Oct 2017|Observational|Apr 2016|Hepatitis C,Hepatitis|Interferons,Ritonavir,Ribavirin,Interferon-alpha,Interferon alpha-2,Sofosbuvir,Peginterferon alfa-2a,Ledipasvir,Simeprevir\\r\\nNCT02751970|Universidad de Valparaiso|Unknown status|Apr 2014|Apr 2018|Interventional|Apr 2016|Dental Caries|\\r\\nNCT02753712|Mundipharma Research Limited|Completed|Jun 2016|Aug 2017|Interventional|Apr 2016|Asthma|Fluticasone,Xhance,Formoterol Fumarate\\r\\nNCT02751151|Inova Health Care Services|Completed|Feb 2016|May 2021|Interventional|Mar 2016|Skin Neoplasms|Aminolevulinic Acid\\r\\nNCT02757716|Sana Klinikum Offenbach|Completed|Apr 2016|Jan 2019|Interventional|Apr 2016|Behavior|\\r\\nNCT02758652|Tampere University Hospital|Active, not recruiting|May 2016|May 2026|Observational|Apr 2016|Ovarian Neoplasms,Carcinoma|\\r\\nNCT02754206|Southern Methodist University|Terminated|Jan 2016|Sep 2021|Observational|Apr 2016|Post-Concussion Syndrome,Brain Concussion|\\r\\nNCT02752243|Peter Bader|Active, not recruiting|Mar 2016|Mar 2022|Interventional|Mar 2016|Leukemia,Preleukemia,Myelodysplastic Syndromes,Syndrome,Acute Disease|\\r\\nNCT02754856|M.D. Anderson Cancer Center|Active, not recruiting|Jul 2016|Jul 2021|Interventional|Apr 2016|Colorectal Neoplasms|Durvalumab,Ipilimumab,Tremelimumab,Immunoglobulins,Antibodies,Immunoglobulin G\\r\\nNCT02759861|University of Nebraska|Active, not recruiting|Aug 2016|Aug 2020|Interventional|Apr 2016|Hepatitis A,Hepatitis C,Hepatitis|Sofosbuvir,Ledipasvir\\r\\nNCT02759679|Haukeland University Hospital|Unknown status|May 2016|Dec 2019|Interventional|Mar 2016|Lung Neoplasms|\\r\\nNCT02752932|Lawson Health Research Institute|Completed|Nov 2015|Oct 2017|Interventional|Feb 2016|Carcinoma,Squamous Cell Carcinoma of Head and Neck,Neoplasms|\\r\\nNCT02759445|RWTH Aachen University|Unknown status|Apr 2016|Oct 2016|Observational|Nov 2015||\\r\\nNCT02754622|Guy's and St Thomas' NHS Foundation Trust|Completed|Jul 2016|Dec 2016|Observational|Apr 2016|Critical Illness|\\r\\nNCT02756611|AbbVie|Active, not recruiting|Jun 2016|Sep 2022|Interventional|Apr 2016|Leukemia|Venetoclax\\r\\nNCT02758223|Wuerzburg University Hospital|Active, not recruiting|Apr 2016|Jun 2021|Interventional|Feb 2016|Leukemia,Myelodysplastic Syndromes|\\r\\nNCT02757079|Nobelpharma|Completed|Jun 2016|Jul 2018|Interventional|Apr 2016|Sleep Wake Disorders,Parasomnias,Disease,Neurodevelopmental Disorders|Melatonin\\r\\nNCT02754219|Dong-A ST Co., Ltd.|Completed|Sep 2016|Jan 2018|Interventional|Apr 2016|Liver Diseases|\\r\\nNCT02753101|Stanford University|Completed|Feb 2016|Feb 2017|Interventional|Apr 2016|Complex Regional Pain Syndromes,Reflex Sympathetic Dystrophy,Sciatica|\\r\\nNCT02759003|Fondazione Salvatore Maugeri|Completed|Mar 2011|Mar 2014|Interventional|Apr 2016|Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Sclerosis|\\r\\nNCT02752659|University of British Columbia|Completed|Jun 2016|Jun 2017|Interventional|Apr 2016|Breast Neoplasms,Lymphedema|\\r\\nNCT02758912|Burnasyan Federal Medical Biophysical Center|Completed|Nov 2016|Oct 2019|Interventional|Apr 2016|Stroke,Angina Pectoris,Infarction,Hemorrhage|\\r\\nNCT02754388|National Taiwan University Hospital|Completed|Feb 2016|Dec 2019|Observational [Patient Registry]|Apr 2016|Lung Neoplasms|\\r\\nNCT02759666|Atridia Pty Ltd.|Completed|Jun 2016|Apr 2019|Interventional|Apr 2016|Neoplasms|\\r\\nNCT02750241|The University of Texas Medical Branch, Galveston|Completed|Apr 2016|Jan 2019|Interventional|Apr 2016|Breast Neoplasms|\\r\\nNCT02752568|Kasr El Aini Hospital|Unknown status|May 2016|Dec 2016|Interventional|Apr 2016||\\r\\nNCT02758015|University of California, San Francisco|Completed|Jun 2016|Mar 2018|Interventional|Apr 2016||Betaine\\r\\nNCT02756884|Arkansas Heart Hospital|Completed|Jun 2015|Jan 2019|Interventional|Apr 2016|Peripheral Arterial Disease,Peripheral Vascular Diseases|\\r\\nNCT02758353|JSI Research & Training Institute, Inc.|Completed|Apr 2015|Nov 2015|Interventional|Apr 2016|Malaria,Stillbirth|\\r\\nNCT02753751|Yale University|Completed|Mar 2018|Jan 2020|Interventional|Apr 2016|Acute Kidney Injury,Wounds and Injuries|\\r\\nNCT02757170|All India In\n\n*** WARNING: max output size exceeded, skipping output. ***\n\nional|Apr 2016||\\r\\nNCT02751047|Seoul National University Hospital|Completed|May 2016|Jan 2017|Interventional|Apr 2016||\\r\\nNCT02758197|Ottawa Hospital Research Institute|Completed|Jul 2016|Oct 2020|Interventional|Apr 2016|Neuralgia,Chronic Pain|\\r\\nNCT02753270|University of Sao Paulo|Completed|Dec 2014|Apr 2017|Interventional|Apr 2016|Varicose Veins|\\r\\nNCT02750839|Azienda Ospedaliera Bolognini di Seriate Bergamo|Unknown status|Apr 2016|Apr 2016|Observational|Apr 2016|Osteoporosis,Fractures,Humeral Fractures|\\r\\nNCT02750488|Bayer|Completed|May 2016|Jul 2016|Interventional|Apr 2016|Dermatitis|\\r\\nNCT02752958|GlaxoSmithKline|Completed|May 2016|Feb 2017|Interventional|Apr 2016|Dentin Sensitivity,Hypersensitivity|Fluorides,Tin Fluorides\\r\\nNCT02753322|The Queen Elizabeth Hospital|Unknown status|Apr 2016|Mar 2018|Interventional|Apr 2016|Stroke|\\r\\nNCT02757261|University of Nove de Julho|Unknown status|Jun 2016|Mar 2017|Interventional|Apr 2016|Bruxism,Sleep Bruxism|Salicylic Acid\\r\\nNCT02754427|University of British Columbia|Completed|Feb 2013|Aug 2015|Interventional|Apr 2016|Breast Neoplasms|\\r\\nNCT02758366|Meyer Children's Hospital|Terminated|Feb 2016|Jan 2020|Interventional|Apr 2016|Glioblastoma,Glioma,Astrocytoma,Diffuse Intrinsic Pontine Glioma,Neoplasms|Doxorubicin\\r\\nNCT02755402|Centre hospitalier de l'Université de Montréal (CHUM)|Completed|Jan 2017|May 2021|Interventional|Apr 2016|Hepatitis C|\\r\\nNCT02754453|The Cleveland Clinic|Withdrawn|Jul 2013|Oct 2015|Interventional|Sep 2013|Body Weight,Weight Loss|\\r\\nNCT02755103|Medical University of South Carolina|Active, not recruiting|Jun 2016|Oct 2021|Interventional|Apr 2016|Disease,Substance-Related Disorders,Stress Disorders|\\r\\nNCT02758834|Università Politecnica delle Marche|Completed|Jan 2014|Apr 2016|Observational|Apr 2016|Liver Diseases|\\r\\nNCT02759146|Michigan State University|Completed|May 2016|Nov 2019|Interventional|Apr 2016||\\r\\nNCT02754414|Bloodworks|Unknown status|Apr 2016|Jan 2019|Interventional|Apr 2016||\\r\\nNCT02759783|Royal Marsden NHS Foundation Trust|Active, not recruiting|Nov 2016|Oct 2024|Interventional|Apr 2016|Carcinoma|\\r\\nNCT02756923|Weill Medical College of Cornell University|Suspended|Apr 2012|Dec 2025|Observational|Apr 2016|Infertility|\\r\\nNCT02759237|Medtronic Cardiovascular|Terminated|Feb 2016|May 2017|Observational|Apr 2016|Aortic Valve Stenosis|\\r\\nNCT02757391|M.D. Anderson Cancer Center|Terminated|Aug 2019|Oct 2020|Interventional|Apr 2016|Carcinoma,Colorectal Neoplasms,Adenocarcinoma,Stomach Neoplasms,Esophageal Neoplasms,Cholangiocarcinoma|Aldesleukin,Cyclophosphamide,Pembrolizumab,Interleukin-2,Immunologic Factors\\r\\nNCT02750904|Fred Hutchinson Cancer Research Center|Completed|Apr 2017|May 2019|Interventional|Mar 2016|Disease,Bipolar Disorder|Nicotine\\r\\nNCT02758418|Universitat Jaume I|Unknown status|Apr 2016|Jul 2019|Interventional|Apr 2016|Adjustment Disorders|\\r\\nNCT02756039|AstraZeneca|Completed|May 2016|Aug 2018|Observational|Apr 2016||\\r\\nNCT02755077|Massachusetts General Hospital|Completed|Jul 2014|Jan 2016|Interventional|Apr 2016||\\r\\nNCT02751801|Sheffield Teaching Hospitals NHS Foundation Trust|Completed|Nov 2016|Dec 2017|Observational|Apr 2016|Hypophosphatasia|\\r\\nNCT02751177|Institut de Cancérologie de Lorraine|Completed|Mar 2016|May 2017|Interventional|Mar 2016|Colorectal Neoplasms|\\r\\nNCT02758574|University of Pittsburgh|Completed|May 2016|Aug 2021|Interventional|Mar 2016|Pulmonary Embolism,Embolism|\\r\\nNCT02758587|NHS Greater Glasgow and Clyde|Recruiting|Jul 2017|Dec 2021|Interventional|Apr 2016|Mesothelioma,Carcinoma,Pancreatic Neoplasms|Pembrolizumab\\r\\nNCT02752100|Third Military Medical University|Unknown status|Mar 2016|May 2020|Interventional|Mar 2016|Arterial Occlusive Diseases|\\r\\nNCT02755818|University of California, Davis|Terminated|Oct 2008|Feb 2019|Observational|Mar 2016|Insulin Resistance|Heparin,Calcium heparin\\r\\nNCT02752906|Sanofi Pasteur, a Sanofi Company|Completed|Apr 2016|Dec 2016|Interventional|Apr 2016|Meningococcal Infections,Meningitis|Vaccines\\r\\nNCT02750371|University Hospital, Bordeaux|Active, not recruiting|Jul 2016|Oct 2021|Interventional|Apr 2016|Adenoma,Meningioma,Pituitary Neoplasms,Pituitary Diseases|\\r\\nNCT02751125|University of Bergen|Completed|Jun 2014|Mar 2020|Interventional|Mar 2016|Atrophy|\\r\\nNCT02754700|High Point University|Completed|Apr 2016|Feb 2019|Interventional|Apr 2016|Knee Injuries|\\r\\nNCT02756442|Assistance Publique Hopitaux De Marseille|Unknown status|Apr 2016|Apr 2019|Interventional|Apr 2016|Respiration Disorders,Respiratory Tract Diseases,Diabetes|\\r\\nNCT02756637|Abramson Cancer Center of the University of Pennsylvania|Completed|Apr 2016|Nov 2016|Observational|Apr 2016|Urinary Bladder Neoplasms|\\r\\nNCT02755688|Royal Brompton & Harefield NHS Foundation Trust|Unknown status|Jun 2015|Mar 2020|Interventional|Apr 2016|Atrial Fibrillation|\\r\\nNCT02753387|Rennes University Hospital|Completed|May 2016|Sep 2018|Interventional|Apr 2016|Bacterial Infections,Head and Neck Neoplasms|Chlorhexidine\\r\\nNCT02758470|University of British Columbia|Completed|Nov 2016|Jun 2017|Interventional|Apr 2016|Fatigue,Hypoxia|Acetazolamide,Methazolamide\\r\\nNCT02754375|Centre Hospitalier Universitaire de Nice|Unknown status|May 2016|May 2019|Interventional|Apr 2016|Depression,Depressive Disorder|\\r\\nNCT02758756|University of Rochester|Completed|Jun 2016|May 2019|Interventional|Apr 2016|Fatigue|\\r\\nNCT02750787|Abbott Nutrition|Completed|Aug 2016|Jul 2017|Interventional|Apr 2016|Malabsorption Syndromes|\\r\\nNCT02757339|Mclean Hospital|Enrolling by invitation|Jun 2015|May 2022|Observational|Mar 2016|Disease,Stress Disorders,Dissociative Disorders,Dissociative Identity Disorder|\\r\\nNCT02753959|Guy's and St Thomas' NHS Foundation Trust|Completed|Aug 2016|Sep 2019|Interventional|Apr 2016|Neuromuscular Diseases|\\r\\nNCT02753426|University of California, San Francisco|Completed|Apr 2016|Jan 2018|Interventional|Apr 2016|Kidney Diseases,Renal Insufficiency,Cardio-Renal Syndrome|Doxycycline\\r\\nNCT02757183|AnalyticsPlus, Inc.|Unknown status|Apr 2016|Mar 2017|Observational|Apr 2016||\\r\\nNCT02750293|University of Tromso|Completed|Jun 2015|Sep 2017|Interventional|Apr 2016|Vitamin D Deficiency|Cholecalciferol\\r\\nNCT02757274|European Association of Urology Research Foundation|Recruiting|Feb 2017|Jul 2027|Observational [Patient Registry]|Apr 2016|Urinary Incontinence,Enuresis|\\r\\nNCT02756741|All India Institute of Medical Sciences, New Delhi|Completed|Apr 2014|Jul 2015|Interventional|Apr 2016|Peritonitis,Fibrosis|\\r\\nNCT02758964|Charite University, Berlin, Germany|Completed|Sep 2016|Jan 2019|Observational|Apr 2016|Intracranial Embolism,Embolism,Aortic Valve Stenosis|\\r\\nNCT02753439|The Baruch Padeh Medical Center, Poriya|Unknown status|Feb 2017|Feb 2019|Interventional|Mar 2016|Tooth|\\r\\nNCT02751281|Isfahan University of Medical Sciences|Completed|Dec 2014|Apr 2016|Interventional|Apr 2016|Kidney Calculi,Nephrolithiasis|\\r\\nNCT02756676|Ospedale Generale Di Zona Moriggia-Pelascini|Completed|Apr 2015|Dec 2016|Interventional|Apr 2016|Parkinson Disease|\\r\\nNCT02750215|Massachusetts General Hospital|Completed|May 2016|May 2021|Interventional|Apr 2016|Lung Neoplasms|\\r\\nNCT02755935|Cochlear|Completed|May 2016|Sep 2017|Interventional|Apr 2016|Hearing Loss|\\r\\nNCT02759523|Penn State University|Completed|Jul 2013|Dec 2015|Observational|Apr 2016|Pediatric Obesity|\\r\\nNCT02756533|University Hospital, Grenoble|Recruiting|Aug 2016|Aug 2021|Interventional|Mar 2016|Lung Diseases,Pulmonary Disease,Signs and Symptoms|\\r\\nNCT02752841|Brown University|Terminated|May 2016|May 2019|Interventional|Apr 2016|Kidney Calculi,Calculi|Vitamin D\\r\\nNCT02758392|Janssen Research & Development, LLC|Completed|Apr 2016|Jan 2017|Interventional|Apr 2016||\\r\\nNCT02755870|Clene Nanomedicine|Completed|Apr 2015|Oct 2016|Interventional|Apr 2016||\\r\\nNCT02752464|Boston Medical Center|Completed|Sep 2016|Jun 2018|Interventional|Apr 2016||\\r\\nNCT02756780|Royal Marsden NHS Foundation Trust|Unknown status|Apr 2016|Apr 2018|Interventional|Apr 2016||\\r\\nNCT02753998|Assistance Publique - Hôpitaux de Paris|Active, not recruiting|Dec 2016|Sep 2021|Interventional|Apr 2016|Arteriovenous Fistula,Constriction,Fistula|Paclitaxel\\r\\nNCT02751307|Taipei Medical University WanFang Hospital|Completed|May 2013|Jan 2015|Interventional|Apr 2016|Congenital Abnormalities,Metabolic Syndrome,Schizophrenia|Metformin,Clozapine\\r\\nNCT02757755|Armata Pharmaceuticals, Inc.|Completed|May 2016|Aug 2016|Interventional|Apr 2016||\\r\\nNCT02753972|University of New Mexico|Completed|Aug 2006|Jan 2008|Interventional|Apr 2016||\\r\\nNCT02751853|University of Luebeck|Unknown status|Dec 2016|Aug 2020|Interventional|Apr 2016|Heart Failure|\\r\\nNCT02752971|Hospital Central Dr. Luis Ortega|Completed|Feb 2015||Interventional|Mar 2016|Pain|Diclofenac,Bupivacaine\\r\\nNCT02755012|McGill University|Completed|Jun 2012|Nov 2013|Observational|Apr 2016|Infections,Mastitis,Malnutrition,Infant Nutrition Disorders,Growth Disorders,Stress|\\r\\nNCT02751996|F-star Therapeutics, Inc.|Completed|May 2016|Feb 2020|Interventional|Apr 2016|Hepatitis A,Hepatitis B,Hepatitis|Tenofovir\\r\\nNCT02752893|Dartmouth-Hitchcock Medical Center|Completed|Jan 2017|Apr 2019|Observational|Apr 2016|Breast Neoplasms|\\r\\nNCT02753842|Global Protection Corp.|Completed|May 2016|Jul 2017|Interventional|Apr 2016||\\r\\nNCT02757040|Peking University People's Hospital|Unknown status|Dec 2016|Dec 2018|Interventional|Apr 2016|Leukemia|Arsenic Trioxide\\r\\nNCT02751606|Radboud University|Unknown status|Jun 2015|Nov 2019|Interventional|Nov 2014|Neoplasms,Breast Neoplasms,Rectal Neoplasms|\\r\\nNCT02751372|Bayer|Completed|May 2016|May 2016|Interventional|Apr 2016||\\r\\nNCT02753764|National Jewish Health|Completed|Jan 2017|Feb 2019|Interventional|Apr 2016|Asthma|Prednisone,AZD7624\\r\\nNCT02758938|University of Wisconsin, Madison|Completed|Jun 2016|Sep 2018|Interventional|Dec 2015|Lower Urinary Tract Symptoms|\\r\\nNCT02752399|Federal University of São Paulo|Unknown status|Apr 2016|Jun 2017|Observational|Apr 2016|Hypertension,Heart Defects,Eisenmenger Complex|\\r\\nNCT02753296|University of Sheffield|Unknown status|May 2016|Jun 2018|Observational|Apr 2016||\\r\\nNCT02759432|Teesside University|Completed|May 2016|Jul 2016|Interventional|Apr 2016||\\r\\nNCT02750137|KK Women's and Children's Hospital|Completed|Aug 2014|May 2015|Observational|Apr 2016|Drug-Related Side Effects and Adverse Reactions|Tetracaine\\r\\nNCT02754466|University of Brasilia|Terminated|May 2017|Sep 2021|Interventional|Apr 2016|Dental Caries|\\r\\nNCT02752191|Paul Finn|Recruiting|Apr 2016|Apr 2021|Interventional|Apr 2016|Heart Diseases,Heart Defects|Ferrosoferric Oxide\\r\\nNCT02753517|University Hospital, Lille|Recruiting|Dec 2015|Nov 2023|Interventional|Apr 2016|Liver Failure,Hepatic Insufficiency|\\r\\nNCT02758054|University of Texas Southwestern Medical Center|Active, not recruiting|Jun 2017|Mar 2023|Interventional|Apr 2016|Carcinoma|\\r\\nNCT02757573|Tampere University Hospital|Active, not recruiting|Apr 2016|Dec 2022|Interventional|Apr 2016|Hypercapnia|\\r\\nNCT02752789|National Institute of Allergy and Infectious Diseases (NIAID)|Completed|Jul 2014|Nov 2019|Observational|Apr 2016||\\r\\nNCT02756416|University of Nottingham|Unknown status|Jul 2016|May 2017|Interventional|Mar 2016|Syndrome|\\r\\nNCT02758106|Chung Shan Medical University|Completed|Feb 2014|Nov 2015|Interventional|Apr 2016|Respiratory Insufficiency|\\r\\nNCT02759159|Xuanwu Hospital, Beijing|Unknown status|Jun 2016|Dec 2018|Interventional|Apr 2016|Alzheimer Disease|\\r\\nNCT02753777|University of Pennsylvania|Recruiting|Apr 2016|Dec 2025|Observational [Patient Registry]|Apr 2016|Pemphigoid,Pemphigus|\\r\\nNCT02754245|Baylor Research Institute|Unknown status|Nov 2016|Jul 2017|Observational|Apr 2016|Emergencies|\\r\\nNCT02754687|Health Decisions|Unknown status|Apr 2016|Jan 2020|Interventional|Mar 2016||Nandrolone Decanoate,Nandrolone,Nandrolone phenpropionate\\r\\nNCT02755337|Dr. Soetomo General Hospital|Unknown status|Jan 2016|Dec 2016|Observational|Apr 2016|Lung Neoplasms|\\r\\nNCT02755090|University of New Mexico|Completed|Jul 2016|May 2017|Interventional|Apr 2016||Nitrous Oxide\\r\\nNCT02751437|Liverpool Women's NHS Foundation Trust|Completed|Aug 2016|Mar 2018|Interventional|Mar 2016|Premature Birth|\\r\\nNCT02757950|GlaxoSmithKline|Completed|Jul 2016|May 2017|Observational|Apr 2016|Diphtheria|\\r\\nNCT02756754|University Hospital, Toulouse|Completed|Nov 2016|May 2019|Interventional|Apr 2016|Adenoma,Adrenocortical Adenoma,Hyperaldosteronism|\\r\\nNCT02754726|HonorHealth Research Institute|Active, not recruiting|Apr 2016|Jun 2022|Interventional|Apr 2016|Adenocarcinoma|Gemcitabine,Paclitaxel,Nivolumab,Albumin-Bound Paclitaxel\\r\\nNCT02759549|Emory University|Withdrawn|Sep 2015||Interventional|Apr 2016|Breast Neoplasms|\\r\\nNCT02755714|Haukeland University Hospital|Completed|Jun 2016|Oct 2020|Interventional|Apr 2016||Bromides,Ipratropium\\r\\nNCT02750358|Memorial Sloan Kettering Cancer Center|Active, not recruiting|May 2016|May 2022|Interventional|Apr 2016|Breast Neoplasms,Triple Negative Breast Neoplasms|\\r\\nNCT02754921|Mohamed Sayed Mohamed Abbas|Completed|Jan 2013||Interventional|Apr 2016||\\r\\nNCT02755259|University of Zurich|Completed|Jan 2017|Apr 2019|Interventional|Mar 2016|Hypertension|Acetazolamide\\r\\nNCT02759081|Dalin Tzu Chi General Hospital|Completed|Jan 2015||Interventional|Apr 2016||\\r\\nNCT02755155|University Hospital, Strasbourg, France|Terminated|Sep 2016|Aug 2019|Interventional|Apr 2016|Hypoalbuminemia,Syndrome,Systemic Inflammatory Response Syndrome|\\r\\nNCT02758119|Ilumens|Completed|Jun 2016|Oct 2016|Interventional|Apr 2016|Heart Arrest,Out-of-Hospital Cardiac Arrest|\\r\\nNCT02755415|China Medical University Hospital|Unknown status|May 2016|Dec 2017|Interventional|Apr 2016|Stroke|\\r\\nNCT02751268|Armed Forces Hampyeong Hospital|Unknown status|Apr 2016|Mar 2017|Interventional|Apr 2016|Psychomotor Agitation,Emergence Delirium|Ropivacaine\\r\\nNCT02756572|University of Washington|Completed|Sep 2016|Jul 2020|Interventional|Apr 2016|Leukemia,Neoplasms,Preleukemia,Myelodysplastic Syndromes,Anemia,Syndrome|Cytarabine,Cyclosporine,Mycophenolic Acid,Sirolimus,Fludarabine,Fludarabine phosphate,Melphalan,Mechlorethamine,Mitoxantrone,Nitrogen Mustard Compounds,Cladribine,2-chloro-3-deoxyadenosine,Cyclosporins,Lenograstim\\r\\nNCT02756871|Institute of Child Health|Completed|Jul 2015|Feb 2017|Interventional|Apr 2016||\\r\\nNCT02750618|Ultragenyx Pharmaceutical Inc|Completed|May 2016|Sep 2019|Interventional|Dec 2015|Familial Hypophosphatemic Rickets,Hypophosphatemia|\\r\\nNCT02757196|Peking University People's Hospital|Unknown status|May 2016|Dec 2018|Interventional|Apr 2016|Thrombocytopenia,Purpura|Methylprednisolone,Methylprednisolone Acetate,Methylprednisolone Hemisuccinate,Prednisolone,Prednisolone acetate,Rituximab,Prednisolone hemisuccinate,Prednisolone phosphate\\r\\nNCT02758093|University of Alabama at Birmingham|Completed|Sep 2016|Mar 2020|Interventional|Mar 2016||\\r\\nNCT02750943|GlaxoSmithKline|Completed|Nov 2015|Mar 2016|Interventional|Nov 2015|Gingivitis|Fluorides,Tin Fluorides,Fluorophosphate\\r\\nNCT02754908|The University of Hong Kong|Completed|Jan 2016|Jun 2018|Interventional|Apr 2016|Brain Neoplasms|\\r\\nNCT02750514|Bristol-Myers Squibb|Terminated|May 2016|Jan 2020|Interventional|Apr 2016|Carcinoma|Nivolumab,Ipilimumab,Dasatinib,Linrodostat\\r\\nNCT02755350|LVCT Health|Unknown status|Aug 2015|Apr 2017|Interventional|Nov 2015||Emtricitabine\\r\\nNCT02753374|Beijing Children's Hospital|Not yet recruiting|May 2016|Jul 2030|Observational|Apr 2016|Cystic Fibrosis,Fibrosis|\\r\\nNCT02759419|Bayer|Recruiting|Jun 2016|Dec 2023|Interventional|Apr 2016|Pulmonary Arterial Hypertension,Hypertension|Riociguat\\r\\nNCT02757612|Universidad de Murcia|Completed|Jun 2015|Jul 2016|Interventional|Apr 2016|Burning Mouth Syndrome,Syndrome,Burns|\\r\\nNCT02754297|CHU de Quebec-Universite Laval|Recruiting|Apr 2016|Dec 2026|Interventional|Mar 2016|Neoplasms,Neuroendocrine Tumors,Carcinoid Tumor,Carcinoma|Lutetium Lu 177 dotatate\\r\\nNCT02758665|University of Ulm|Active, not recruiting|Sep 2016|Mar 2022|Interventional|Apr 2016|Leukemia|Venetoclax,Obinutuzumab\\r\\nNCT02755285|Fujifilm Medical Systems USA, Inc.|Completed|Aug 2016|Oct 2016|Interventional|Apr 2016||\\r\\nNCT02757690|Asan Medical Center|Completed|Jan 2015|Feb 2016|Interventional|Apr 2016|Neoplasms,Brain Neoplasms|\\r\\nNCT02753218|LEO Pharma|Terminated|Apr 2016|May 2016|Interventional|Apr 2016|Psoriasis|Midazolam\\r\\nNCT02754986|University of Hyogo|Completed|Mar 2015||Interventional|Mar 2016|Kidney Diseases,Renal Insufficiency|\\r\\nNCT02752048|Taiho Pharmaceutical Co., Ltd.|Completed|May 2016|Oct 2017|Interventional|Apr 2016|Muscular Dystrophies,Muscular Dystrophy|\\r\\nNCT02752256|University of Iowa|Completed|Oct 2015|Oct 2017|Observational|Apr 2016||Plasminogen,Tissue Plasminogen Activator\\r\\nNCT02756936|Genuine Research Center, Egypt|Completed|Feb 2016|Mar 2016|Interventional|Apr 2016||\\r\\nNCT02756000|Clinical Hospital Center Zemun|Unknown status|Jan 2016|Jul 2018|Interventional|Apr 2016|Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Myocardial Infarction,Infarction|Dobutamine\\r\\nNCT02754492|Terumo BCT|Completed|Apr 2016|Feb 2017|Interventional|Apr 2016||\\r\\nNCT02757677|Swiss Vision Network|Unknown status|Dec 2015|Dec 2019|Observational|Apr 2016|Glaucoma|\\r\\nNCT02752373|Brain Sentinel|Terminated|May 2016|Feb 2017|Observational|Mar 2016|Epilepsy,Seizures|\\r\\nNCT02752230|Kettering Health Network|Withdrawn|Nov 2016|Jun 2021|Interventional|Mar 2016|Pain|\\r\\nNCT02756728|BioInvent International AB|Terminated|May 2016|Dec 2016|Interventional|Apr 2016|Multiple Myeloma,Neoplasms|Melphalan\\r\\nNCT02751658|University Hospital, Montpellier|Completed|Nov 2016|Jul 2019|Interventional|Mar 2016|Otorhinolaryngologic Diseases|\\r\\nNCT02754518|University of Chicago|Completed|Apr 2016|Apr 2019|Interventional|Apr 2016|Heart Failure|Valsartan,Sacubitril and valsartan sodium hydrate drug combination\\r\\nNCT02759380|Sahlgrenska University Hospital, Sweden|Recruiting|Mar 2016|Oct 2022|Interventional|Apr 2016|Prostatic Neoplasms|Phytoestrogens\\r\\nNCT02755649|Regeneron Pharmaceuticals|Completed|Jan 2016|Mar 2017|Interventional|Mar 2016|Dermatitis,Eczema|\\r\\nNCT02751827|Institut Bergonié|Completed|Feb 2016|Nov 2019|Observational|Apr 2016||\\r\\nNCT02755545|Galderma Laboratories, L.P.|Completed|May 2016|Apr 2017|Interventional|Apr 2016|Acne Vulgaris|Salicylic Acid,Adapalene,Salicylates\\r\\nNCT02750345|Cycle Pharmaceuticals Ltd.|Completed|Mar 2016|May 2016|Interventional|Apr 2016|Tyrosinemias|Nitisinone\\r\\nNCT02755532|Federal University of São Paulo|Completed|Jan 2014|Oct 2015|Interventional|Apr 2016||Bupivacaine\\r\\nNCT02758743|Biohit Oyj|Completed|Apr 2016|May 2017|Interventional|Apr 2016||\\r\\nNCT02754947|Nationwide Children's Hospital|Completed|Feb 2015|Mar 2016|Observational|Apr 2016|Respiration Disorders,Respiratory Tract Diseases,Nervous System Diseases,Cardiovascular Diseases|\\r\\nNCT02750280|Calvary Hospital, Bronx, NY|Completed|Jun 2015|Dec 2015|Interventional|Apr 2016|Diabetic Foot,Foot Ulcer,Ulcer|\\r\\nNCT02756325|NYU Langone Health|Withdrawn|Jun 2016|Jan 2019|Interventional|Apr 2016|Infertility|\\r\\nNCT02758717|Academic and Community Cancer Research United|Active, not recruiting|May 2016|May 2024|Interventional|Apr 2016|Lymphoma,Hodgkin Disease|Antineoplastic Agents,Nivolumab,Brentuximab Vedotin,Antibodies,Immunoglobulins,Immunoconjugates\\r\\nNCT02751034|Medy-Tox|Completed|Jun 2013|Jan 2014|Interventional|Apr 2015||Lidocaine\\r\\nNCT02751476|Action Contre la Faim|Unknown status|Apr 2016|Mar 2017|Interventional|Apr 2016|Malnutrition,Severe Acute Malnutrition,Protein-Energy Malnutrition|Disinfectants\\r\\nNCT02755454|University Health Network, Toronto|Completed|Oct 2013|Nov 2018|Interventional|Mar 2016|Lung Neoplasms|\\r\\nNCT02752867|Dongfang Hospital Beijing University of Chinese Medicine|Unknown status|Dec 2016|Nov 2019|Interventional|Mar 2016|Cerebral Infarction,Infarction,Cognitive Dysfunction|\\r\\nNCT02754830|Eli Lilly and Company|Completed|Apr 2016|Jul 2018|Interventional|Apr 2016|Alzheimer Disease|\\r\\nNCT02753738|Medical University of Vienna|Unknown status|Aug 2016||Interventional|Apr 2016||Citalopram\\r\\nNCT02750267|University of Virginia|Completed|May 2016|May 2016|Interventional|Apr 2016|Diabetes Mellitus|\\r\\nNCT02754999|Prolong Pharmaceuticals|Completed|Mar 2016|May 2017|Interventional|Apr 2016|Anemia|\\r\\nNCT02754843|Sonova AG|Completed|Oct 2015||Interventional|Oct 2015|Hearing Loss|\\r\\nNCT02759055|HealthPartners Institute|Completed|Oct 2016|Dec 2019|Interventional|Apr 2016|Prediabetic State,Glucose Intolerance|\\r\\nNCT02753673|Memorial Sloan Kettering Cancer Center|Completed|Apr 2016|Apr 2020|Observational|Apr 2016||\\r\\nNCT02754531|Indonesia University|Completed|May 2016|Jul 2016|Interventional|Apr 2016||\\r\\nNCT02750033|Seton Healthcare Family|Withdrawn|Oct 2016|Mar 2017|Observational|Apr 2016|Carcinoma|\\r\\nNCT02759133|Centre Antoine Lacassagne|Recruiting|Jun 2016|Nov 2022|Interventional|Apr 2016|Breast Neoplasms|\\r\\nNCT02756650|Novartis Pharmaceuticals|Completed|Jun 2016|Jan 2019|Interventional|Mar 2016|Behcet Syndrome|\\r\\nNCT02752152|Institut de Recherche pour le Developpement|Completed|Dec 2015|Oct 2020|Interventional|Apr 2016|Hepatitis A,Hepatitis C,Hepatitis B,Syphilis,Hepatitis|\\r\\nNCT02751385|Boehringer Ingelheim|Terminated|May 2016|Nov 2017|Interventional|Apr 2016|Carcinoma|Nintedanib,Ethinyl estradiol,Ethinyl Estradiol-Norgestrel Combination\\r\\nNCT02751879|Boehringer Ingelheim|Completed|Nov 2016|Sep 2017|Observational|Apr 2016|Carcinoma|\\r\\nNCT02756663|Novartis Pharmaceuticals|Withdrawn|Dec 2016|Feb 2021|Interventional|Apr 2016|Multiple Myeloma,Neoplasms|Dexamethasone,Panobinostat\\r\\nNCT02756273|Centre Hospitalier Universitaire, Amiens|Recruiting|May 2016|May 2022|Interventional|Apr 2016||\\r\\nNCT02755974|Imperial College London|Unknown status|Jan 2009|Apr 2021|Observational|Apr 2016|Lung Diseases,Pulmonary Disease|\\r\\nNCT02756507|Babes-Bolyai University|Completed|Jun 2016|Jun 2018|Interventional|Apr 2016|Disease,Depression,Anxiety Disorders,Panic Disorder|\\r\\nNCT02750553|Jiangsu HengRui Medicine Co., Ltd.|Completed|Jan 2015||Interventional|Apr 2016||\\r\\nNCT02750228|Mednax Center for Research, Education, Quality and Safety|Completed|May 2016|Jun 2020|Observational|Mar 2016|Ductus Arteriosus|\\r\\nNCT02751710|Ontario Clinical Oncology Group (OCOG)|Recruiting|Dec 2016|Dec 2022|Interventional|Apr 2016|Breast Neoplasms|\\r\\nNCT02753361|Suez Canal University|Completed|May 2016|Dec 2016|Interventional|Apr 2016|Lipoma|\\r\\nNCT02753634|Lawson Health Research Institute|Completed|Apr 2015|Jun 2016|Interventional|Mar 2016|Osteoarthritis|\\r\\nNCT02759250|argenx|Completed|Feb 2015|Jun 2018|Interventional|Apr 2016|Nasopharyngeal Carcinoma|\\r\\nNCT02757482|Celal Bayar University|Completed|Sep 2014|Jun 2015|Interventional|Apr 2016||\\r\\nNCT02757105|RedHill Biopharma Limited|Completed|May 2016|Jul 2017|Interventional|Apr 2016|Irritable Bowel Syndrome,Syndrome,Diarrhea|Ondansetron\\r\\nNCT02756520|Fresenius Kabi|Completed|Sep 2016|Oct 2018|Observational|Apr 2016|Kidney Diseases,Renal Insufficiency|\\r\\nNCT02753309|The University of Texas Health Science Center at San Antonio|Completed|Jun 2016|Mar 2021|Interventional|Apr 2016|Urinary Bladder Neoplasms|Sirolimus\\r\\nNCT02756832|Takeda|Completed|Sep 2016|Apr 2018|Observational|Apr 2016|Diabetes Mellitus|Alogliptin\\r\\nNCT02758158|University Health Network, Toronto|Completed|Jan 2016|Feb 2017|Interventional|Mar 2016|Thyroid Neoplasms,Thyroid Nodule,Thyroid Diseases|\\r\\nNCT02752360|Beijing Friendship Hospital|Unknown status|Apr 2016|Dec 2018|Interventional|Apr 2016|Colonic Neoplasms,Crohn Disease,Diverticulum,Diverticular Diseases,Diverticulosis|\\r\\nNCT02757794|Assistance Publique Hopitaux De Marseille|Recruiting|Nov 2016|Jun 2022|Interventional|Apr 2016|Memory Disorders|\\r\\nNCT02751346|Washington University School of Medicine|Completed|Jan 2016|Feb 2017|Observational|Apr 2016|Pain|\\r\\nNCT02757027|Konkuk University Medical Center|Unknown status|May 2016|Jan 2017|Interventional|Apr 2016||\\r\\nNCT02756689|University of Alabama at Birmingham|Completed|Mar 2016|Oct 2017|Interventional|Apr 2016||\\r\\nNCT02751164|Intensive Care National Audit & Research Centre|Completed|Apr 2013|May 2016|Observational|Apr 2016|Critical Illness|\\r\\nNCT02754765|Médecins Sans Frontières, France|Recruiting|Dec 2016|Aug 2023|Interventional|Apr 2016|Tuberculosis,Bacterial Infections|Moxifloxacin,Levofloxacin,Ofloxacin,Linezolid,Pyrazinamide,Bedaquiline,Clofazimine\\r\\nNCT02757729|Amorepacific Corporation|Completed|Oct 2015||Interventional|Apr 2016|Dermatitis,Eczema|\\r\\nNCT02751866|University of Cincinnati|Recruiting|Jan 2016|Jul 2023|Interventional|Apr 2016|Overweight,Hyperphagia|\\r\\nNCT02759068|Hospices Civils de Lyon|Completed|Nov 2014|May 2017|Interventional|Apr 2016|Consciousness Disorders|\\r\\nNCT02752503|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|Un\""]}],"execution_count":0},{"cell_type":"code","source":["\n\nclinicaltrial_2021 = spark.read.csv(\"/FileStore/tables/clinicaltrial_2021.csv/clinicaltrial_2021.csv\", header=True, inferSchema=True, sep = '|')\n"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"98bea5c1-21d8-43f0-8143-7250ef2bea7f","inputWidgets":{},"title":""}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["clinicaltrial_2021.show(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"73da692d-acf1-472b-a2ed-80befea5dedd","inputWidgets":{},"title":""}},"outputs":[{"output_type":"stream","output_type":"stream","name":"stdout","text":["+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+\n|         Id|             Sponsor|              Status|   Start|Completion|                Type|Submission|          Conditions|Interventions|\n+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+\n|NCT02758028|The University of...|          Recruiting|Aug 2005|  Nov 2021|      Interventional|  Apr 2016|                null|         null|\n|NCT02751957|     Duke University|           Completed|Jul 2016|  Jul 2020|      Interventional|  Apr 2016|Autistic Disorder...|         null|\n|NCT02758483|Universidade Fede...|           Completed|Mar 2017|  Jan 2018|      Interventional|  Apr 2016|   Diabetes Mellitus|         null|\n|NCT02759848|Istanbul Medeniye...|           Completed|Jan 2012|  Dec 2014|       Observational|  May 2016|Tuberculosis,Lung...|         null|\n|NCT02758860|University of Rom...|Active, not recru...|Jun 2016|  Sep 2020|Observational [Pa...|  Apr 2016|Diverticular Dise...|         null|\n+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+\nonly showing top 5 rows\n\n"]}],"execution_count":0},{"cell_type":"code","source":["clinicaltrial_2021.printSchema()"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"6e0ddb5e-4bb9-4eaf-8d49-afbc42b30f5c","inputWidgets":{},"title":""}},"outputs":[{"output_type":"stream","output_type":"stream","name":"stdout","text":["root\n |-- Id: string (nullable = true)\n |-- Sponsor: string (nullable = true)\n |-- Status: string (nullable = true)\n |-- Start: string (nullable = true)\n |-- Completion: string (nullable = true)\n |-- Type: string (nullable = true)\n |-- Submission: string (nullable = true)\n |-- Conditions: string (nullable = true)\n |-- Interventions: string (nullable = true)\n\n"]}],"execution_count":0},{"cell_type":"code","source":["#ques 1:The number of studies in the dataset\nclinicaltrial_2021.distinct().count()"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"b734f71a-58b0-4191-bcdc-0c0b98f99bf5","inputWidgets":{},"title":""}},"outputs":[{"output_type":"stream","output_type":"stream","name":"stdout","text":["Out[5]: 387261"]}],"execution_count":0},{"cell_type":"code","source":["#ques 2: Types of studies and their frequencies\nfrom pyspark.sql.functions import col\ntype_counts = clinicaltrial_2021.groupby('Type').count()\ntype_counts = type_counts.select(col('Type'), col('count').alias('2021'))\ntype_counts = type_counts.orderBy('2021', ascending=False)\n\ntype_counts.show()\n"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"9e6d5462-3ce0-4f52-a310-309014a3f597","inputWidgets":{},"title":""}},"outputs":[{"output_type":"stream","output_type":"stream","name":"stdout","text":["+--------------------+------+\n|                Type|  2021|\n+--------------------+------+\n|      Interventional|301472|\n|       Observational| 77540|\n|Observational [Pa...|  8180|\n|     Expanded Access|    69|\n+--------------------+------+\n\n"]}],"execution_count":0},{"cell_type":"code","source":["#ques 3: Top 5 condition with their frequency\nfrom pyspark.sql.functions import col, trim, split, explode\nconditions_df = clinicaltrial_2021.select(explode(split(col(\"Conditions\"), \",\")).alias(\"Condition\")).select(trim(col(\"Condition\")).alias(\"Condition\"))\ncondition_count = conditions_df.groupBy(col(\"Condition\")).count()\ntop_conditions = condition_count.orderBy(col(\"count\").desc()).limit(5)\ntop_conditions.show() "],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"df40a33d-bb35-46c0-98ef-a62c9c2efa12","inputWidgets":{},"title":""}},"outputs":[{"output_type":"stream","output_type":"stream","name":"stdout","text":["+-----------------+-----+\n|        Condition|count|\n+-----------------+-----+\n|        Carcinoma|13389|\n|Diabetes Mellitus|11080|\n|        Neoplasms| 9371|\n| Breast Neoplasms| 8640|\n|         Syndrome| 8032|\n+-----------------+-----+\n\n"]}],"execution_count":0},{"cell_type":"code","source":["#ques 4 prepration\n#importing pharma data\n\npharma = spark.read.csv(\"/FileStore/tables/pharma.csv/pharma.csv\", header=True, inferSchema=True, sep = ',')"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"4b644954-bf9b-4a33-9624-82d15ea800c1","inputWidgets":{},"title":""}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["pharma.show(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"6d8a4eac-d8ef-4997-8132-894b4f789409","inputWidgets":{},"title":""}},"outputs":[{"output_type":"stream","output_type":"stream","name":"stdout","text":["+--------------------+-------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+-------+-----------------------------+------------------+--------------+--------+-------+----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\n|             Company|     Parent_Company|Penalty_Amount|Subtraction_From_Penalty|Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting|Penalty_Year|Penalty_Date|       Offense_Group|     Primary_Offense|   Secondary_Offense|         Description|Level_of_Government|  Action_Type|              Agency|    Civil/Criminal|Prosecution_Agreement|Court|Case_ID|Private_Litigation_Case_Title|Lawsuit_Resolution|Facility_State|    City|Address| Zip|NAICS_Code|   NAICS_Translation|HQ_Country_of_Parent|HQ_State_of_Parent|Ownership_Structure|Parent_Company_Stock_Ticker|Major_Industry_of_Parent|Specific_Industry_of_Parent|         Info_Source|               Notes|\n+--------------------+-------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+-------+-----------------------------+------------------+--------------+--------+-------+----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\n| Abbott Laboratories|Abbott Laboratories|    $5,475,000|                      $0|                                               $5,475,000|        2013|    20131227|government-contra...|False Claims Act ...|kickbacks and bri...|Abbott Laboratori...|            federal|agency action|Justice Departmen...|             civil|                 null| null|   null|                         null|              null|          null|    null|   null|null|      null|                null|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|Abbott Laboratori...|             AbbVie|$1,500,000,000|                      $0|                                           $1,500,000,000|        2012|    20120507|healthcare-relate...|off-label or unap...|                null|Global Health Car...|            federal|agency action|Food and Drug Adm...|civil and criminal|                 null| null|   null|                         null|              null|          null|    null|   null|null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|http://www.justic...|                null|\n|Abbott Laboratori...|             AbbVie|  $126,500,000|                      $0|                                             $126,500,000|        2010|    20101207|government-contra...|False Claims Act ...|                null|Abbott Laboratori...|            federal|agency action|Justice Departmen...|             civil|                 null| null|   null|                         null|              null|          null|    null|   null|null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|Abbott Laboratori...|Abbott Laboratories|       $49,045|                      $0|                                                  $49,045|        2009|    20090305|employment-relate...|wage and hour vio...|Fair Labor Standa...|                null|            federal|agency action|Labor Department ...|             civil|                 null| null|1527129|                         null|              null|   Puerto Rico|San Juan|   null|null|    423450|423450: Medical, ...|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|March 7, 2017 dow...|Date and year are...|\n|      Acclarent Inc.|  Johnson & Johnson|   $18,000,000|                      $0|                                              $18,000,000|        2016|    20160722|government-contra...|False Claims Act ...|                null|California-based ...|            federal|agency action|Justice Departmen...|             civil|                 null| null|   null|                         null|              null|          null|    null|   null|null|      null|                null|                 USA|        New Jersey|    publicly traded|                        JNJ|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n+--------------------+-------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+-------+-----------------------------+------------------+--------------+--------+-------+----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\nonly showing top 5 rows\n\n"]}],"execution_count":0},{"cell_type":"code","source":["pharma.printSchema()"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"18effe1d-a39d-4a12-9310-460fd7460b37","inputWidgets":{},"title":""}},"outputs":[{"output_type":"stream","output_type":"stream","name":"stdout","text":["root\n |-- Company: string (nullable = true)\n |-- Parent_Company: string (nullable = true)\n |-- Penalty_Amount: string (nullable = true)\n |-- Subtraction_From_Penalty: string (nullable = true)\n |-- Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting: string (nullable = true)\n |-- Penalty_Year: integer (nullable = true)\n |-- Penalty_Date: integer (nullable = true)\n |-- Offense_Group: string (nullable = true)\n |-- Primary_Offense: string (nullable = true)\n |-- Secondary_Offense: string (nullable = true)\n |-- Description: string (nullable = true)\n |-- Level_of_Government: string (nullable = true)\n |-- Action_Type: string (nullable = true)\n |-- Agency: string (nullable = true)\n |-- Civil/Criminal: string (nullable = true)\n |-- Prosecution_Agreement: string (nullable = true)\n |-- Court: string (nullable = true)\n |-- Case_ID: string (nullable = true)\n |-- Private_Litigation_Case_Title: string (nullable = true)\n |-- Lawsuit_Resolution: string (nullable = true)\n |-- Facility_State: string (nullable = true)\n |-- City: string (nullable = true)\n |-- Address: string (nullable = true)\n |-- Zip: string (nullable = true)\n |-- NAICS_Code: integer (nullable = true)\n |-- NAICS_Translation: string (nullable = true)\n |-- HQ_Country_of_Parent: string (nullable = true)\n |-- HQ_State_of_Parent: string (nullable = true)\n |-- Ownership_Structure: string (nullable = true)\n |-- Parent_Company_Stock_Ticker: string (nullable = true)\n |-- Major_Industry_of_Parent: string (nullable = true)\n |-- Specific_Industry_of_Parent: string (nullable = true)\n |-- Info_Source: string (nullable = true)\n |-- Notes: string (nullable = true)\n\n"]}],"execution_count":0},{"cell_type":"code","source":["#ques 4:10 most common sponsors that are not pharmaceutical companies, along with the number of clinical trials they have sponsored\nfrom pyspark.sql.functions import col, collect_set\nparent_company_set = set(pharma.select(\"Parent_Company\").distinct().toPandas()[\"Parent_Company\"].tolist())\nclinicaltrial_2021 = clinicaltrial_2021.filter(~col(\"Sponsor\").isin(parent_company_set))\nsponsor_count = clinicaltrial_2021.groupBy(\"Sponsor\").count()\ntop_sponsors = sponsor_count.orderBy(col(\"count\").desc()).limit(10)\ntop_sponsors.show()"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"779083b7-44c1-4f20-b947-72ad70409b3e","inputWidgets":{},"title":""}},"outputs":[{"output_type":"stream","output_type":"stream","name":"stdout","text":["+--------------------+-----+\n|             Sponsor|count|\n+--------------------+-----+\n|National Cancer I...| 3218|\n|M.D. Anderson Can...| 2414|\n|Assistance Publiq...| 2369|\n|         Mayo Clinic| 2300|\n|Merck Sharp & Doh...| 2243|\n|   Assiut University| 2154|\n|Novartis Pharmace...| 2088|\n|Massachusetts Gen...| 1971|\n|    Cairo University| 1928|\n|   Hoffmann-La Roche| 1828|\n+--------------------+-----+\n\n"]}],"execution_count":0},{"cell_type":"code","source":["#ques 5: Plot number of completed studies each month in a given year\nclinicaltrial_2021.select(\"Status\", \"Completion\").show()"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"fc8f574b-1017-4891-a5dd-8012ab2b037e","inputWidgets":{},"title":""}},"outputs":[{"output_type":"stream","output_type":"stream","name":"stdout","text":["+--------------------+----------+\n|              Status|Completion|\n+--------------------+----------+\n|          Recruiting|  Nov 2021|\n|           Completed|  Jul 2020|\n|           Completed|  Jan 2018|\n|           Completed|  Dec 2014|\n|Active, not recru...|  Sep 2020|\n|           Completed|  Jan 2018|\n|      Unknown status|  Jul 2017|\n|      Unknown status|  Nov 2019|\n|           Completed|  Jul 2017|\n|           Completed|  Jan 2021|\n|           Completed|  Oct 2016|\n|           Completed|  Dec 2015|\n|           Completed|  Mar 2016|\n|           Completed|  May 2019|\n|Active, not recru...|  Dec 2021|\n|      Unknown status|  Jun 2017|\n|          Terminated|  Jul 2016|\n|           Completed|  Oct 2019|\n|      Unknown status|  Dec 2018|\n|          Recruiting|  Oct 2022|\n+--------------------+----------+\nonly showing top 20 rows\n\n"]}],"execution_count":0},{"cell_type":"code","source":["#ques 5 final output\nfrom pyspark.sql.functions import *\nclinicaltrial_2021 = spark.table(\"clinicaltrial_2021\")\nresult_df = (clinicaltrial_2021\n             .filter((col(\"Status\") == \"Completed\") & (col(\"Completion\").like(\"%2021%\")))\n             .select(substring(col(\"Completion\"), 1, 3).alias(\"month_abbr\"))\n             .groupBy(\"month_abbr\")\n             .agg(count(\"*\").alias(\"num_completed_studies\"))\n             .orderBy(expr(\"find_in_set(month_abbr, 'Jan,Feb,Mar,Apr,May,Jun,Jul,Aug,Sep,Oct,Nov,Dec')\"))\n            )\n\nresult_df.show()\n"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"36b78567-f3c0-4ae7-907b-d4f73aca4d62","inputWidgets":{},"title":""}},"outputs":[{"output_type":"stream","output_type":"stream","name":"stdout","text":["+----------+---------------------+\n|month_abbr|num_completed_studies|\n+----------+---------------------+\n|       Jan|                 1131|\n|       Feb|                  934|\n|       Mar|                 1227|\n|       Apr|                  967|\n|       May|                  984|\n|       Jun|                 1094|\n|       Jul|                  819|\n|       Aug|                  700|\n|       Sep|                  528|\n|       Oct|                  187|\n+----------+---------------------+\n\n"]}],"execution_count":0},{"cell_type":"code","source":["spark.catalog.listTables()"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"f1ab113f-d966-4069-a3b2-f0d1840aff0a","inputWidgets":{},"title":""}},"outputs":[{"output_type":"stream","output_type":"stream","name":"stdout","text":["Out[14]: [Table(name='clinicaltrial_2021', catalog='spark_catalog', namespace=['default'], description=None, tableType='EXTERNAL', isTemporary=False),\n Table(name='pharma', catalog='spark_catalog', namespace=['default'], description=None, tableType='EXTERNAL', isTemporary=False)]"]}],"execution_count":0},{"cell_type":"code","source":[""],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"rowLimit":10000,"byteLimit":2048000},"nuid":"700186c6-1b81-4c66-be7d-7696b25f8a9e","inputWidgets":{},"title":""}},"outputs":[],"execution_count":0}],"metadata":{"application/vnd.databricks.v1+notebook":{"notebookName":"Zerin_Jahan_df","dashboards":[],"notebookMetadata":{"pythonIndentUnit":4},"language":"python","widgets":{},"notebookOrigID":2130328551471424}},"nbformat":4,"nbformat_minor":0}
